1.Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children – Southern California, March–April 2009. Morbidity and Mortality Weekly Report 2009; 58: 400–402.
2.World Health Organization. Global alert and response, pandemic (H1N1) 2009, frequently asked questions: what is Phase 6? (http://www.who.int/csr/). Accessed 11 June 2009. 3.Korea Centers for Disease Control and Prevention. Newsletter for influenza. (http://www.cdc.go.kr/). Accessed 11 May 2009.
4.Dominguez-Cherit, G, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. Journal of the American Medical Association 2009; 302: 1880–1887.
5.Kumar, A, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Journal of the American Medical Association 2009; 302: 1872–1879.
6.Louie, JK, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. Journal of the American Medical Association 2009; 302: 1896–1902.
7.Rello, J, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1) in Spain. Critical Care 2009; 13: R148.
8.Estenssoro, E, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. American Journal of Respiration and Critical Care Medicine 2010; 182: 41–48.
9.Davies, A, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. Journal of the American Medical Association 2009; 302: 1888–1895.
10.Hancock, K, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New England Journal of Medicine 2009; 361: 1945–1952.
11.Fuhrman, C, et al. Adult intensive care patients with 2009 pandemic influenza A (H1N1) infection. Epidemiology and Infection 2011; 139: 1202–1209.
12.Viasus, D, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clinical Microbiology and Infection 2011; 17: 738–746.
13.Kim, JH, et al. The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. Journal of Korean Medical Science 2010; 25: 1109–1112.
14.Shin, SY, et al. Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatric Pulmonology 2010; 45: 1014–1020.
15.Kim, HS, et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. Journal of Korean Medical Science 2011; 26: 22–27.
16.Echevarria-Zuno, S, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374: 2072–2079.
17.Sundar, S, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010). Clinical Infectious Disease 2011; 52 (Suppl. 1): S75–S82.
18.Miller, MA, et al. The signature features of influenza pandemics – implications for policy. New England Journal of Medicine 2009; 360: 2595–2598.
19.Gooskens, J, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A (H1N1) virus. Journal of the American Medical Association 2009; 301: 1042–1046.
20.Cunha, BA, Thekkel, V, Krilov, L. Nosocomial swine influenza (H1N1) pneumonia: lessons learned from an illustrative case. Journal of Hospital Infection 2010; 74: 278–281.
21.Nicoll, A. A new decade, a new seasonal influenza: the Council of the European Union recommendation on seasonal influenza vaccination [Editorial]. Eurosurveillance 2010; 15: 1–2.
22.Poalillo, FE, Geiling, J, Jimenez, EJ. Healthcare personnel and nosocomial transmission of pandemic 2009 influenza. Critical Care Medicine 2010; 38 (Suppl. 4): e98–102.
23.Vaillant, L, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance 2009; 14: 1–6.
24.Louie, JK, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clinical Infectious Disease 2011; 52: 301–312.
25.Yu, H, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clinical Infectious Disease 2011; 52: 457–465.
26.Cooksley, CD, et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005; 104: 618–628.
27.Zarychanski, R, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Canadian Medical Association Journal 2010; 182: 257–264.
28.Chien, YS, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. Journal of Infection 2010; 60: 168–174.
29.Yu, H, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. British Medical Journal 2010; 341: c4779.
30.Jefferson, T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. British Medical Journal 2009; 339: b5106.
31.Garnacho-Montero, J, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Critical Care Medicine 2003; 31: 2742–2751.
32.Abdel-Ghafar, AN, et al. Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine 2008; 358: 261–273.
33.Nguyen, JT, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrobial Agents and Chemotherapy 2009; 53: 4115–4126.
34.Martin-Loeches, I, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) influenza A infection. Intensive Care Medicine 2011; 37: 272–283.
35.Xu, T, et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. European Respiration Journal 2009; 33: 852–860.
36.Lee, N, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. Journal of Infectious Disease 2009; 200: 492–500.
37.Sprung, CL, et al. Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine 2008; 358: 111–124.
38.Cronin, L, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Critical Care Medicine 1995; 23: 1430–1439.
39.Sprung, CL, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. New England Journal of Medicine 1984; 311: 1137–1143.